Schedule

The 15th Annual Peptide Therapeutics Symposium will be held in a virtual format from 8:00 am to 5:00 pm (PDT) on October 22nd and 23rd, 2020. An interactive poster session will be held each day. Registrants will have access to recorded presentations for 30 days following the close of the meeting.

The link to all Symposium sessions except the poster break out sessions is the same and can be accessed HERE. You can also access the Symposium by clicking any of the presentation titles listed in the schedule.

Thursday, October 22, 2020
8:00 a.m. – 8:15 a.m.	Opening Remarks Phil Dawson, Ph.D. Chairman of the Board, Peptide Therapeutics Foundation Professor of Chemistry, Scripps Research Dean of the Skaggs Graduate School of Chemical and Biological Sciences
8:15 a.m. – 9:45 a.m.	Session I Moderator: Robert Hagopian Director, Peptide Therapeutics Foundation Director Business Development PolyPeptide Group
8:15 a.m. – 8:45 a.m.	From Farm to Pharmacy: A Strawberry-Derived Solution to Oral Protein Delivery Kathryn A. Whitehead, Ph.D. Associate Professor Carnegie Mellon University
8:45 a.m. – 9:15 a.m.	Building Novel Immune Cell Agonist Anti-Cancer Agents out of *Bicycle* Parts Kevin McDonnell, Ph.D. Vice President, Chemistry US Bicycle Therapeutics
9:15 a.m. – 9:45 a.m.	Toward Universal Druggability Greg Verdine, Ph.D. Erving Professor of Chemistry Harvard University and Harvard Medical School President and Chief Executive Officer Fog Pharmaceuticals and LifeMine Therapeutics
9:45 a.m. – 10:30 a.m.	Break
10:30 a.m. – 12:50 p.m.	Poster Break Out Sessions
12:50 p.m. – 1:30 p.m.	Lunch Break
1:30 p.m. – 3:00 p.m.	Session II Moderator: David Parkes, Ph.D. Chief Scientific Officer, Advance Therapeutics, Inc.
1:30 p.m. – 2:00 p.m.	Adrenomedullin Functions at the Maternal-Fetal Interface Kathleen Caron, Ph.D. Professor & Chair, Department of Cell Biology and Physiology University of North Carolina at Chapel Hill
2:00 p.m. – 2:30 p.m.	Empowering Peptide Science through Easy 18F-labeling for PET Imaging and New Stapling Methods Inspired by Natural Product Toxins David M. Perrin, Ph.D. Professor, Chemistry Department, University of British Columbia
2:30 p.m. – 3:00 p.m.	A Peptide Engineering Platform for PEG-FA Stapled Long-acting Peptide Hormones Weijun Shen, Ph.D. Director, Metabolic Disease Calibr at Scripps Research
3:00 p.m. – 3:30 p.m.	Break
3:30 p.m. – 5:00 p.m.	Plenary Lectures Moderator: Adam Mezo, Ph.D. Director, Peptide Therapeutics Foundation Sr. Director, Discovery Chemistry Ferring Research Institute
3:30 p.m. – 4:15 p.m.	Novel Therapeutics for Inflammatory Disorders of Pregnancy – Opportunities and Challenges Sarah Robertson, Ph.D. FAA FAHMS Professor and Director, Robinson Research Institute The University of Adelaide
4:15 p.m. – 5:00 p.m.	Deadly Cures: A Spider-Venom Peptide for Treating Ischemic Injuries of the Heart and Brain Glenn King, Ph.D. Institute for Molecular Bioscience, The University of Queensland
Friday, October 23, 2020
8:00 a.m. – 8:15 a.m.	Welcoming Remarks Soumitra Ghosh, Ph.D. Director and President, Peptide Therapeutics Foundation President, Doon Associates LLC
8:15 a.m. – 9:45 a.m.	Session III Moderator: Richard DiMarchi, Ph.D. Chairman Emeritus, Peptide Therapeutics Foundation Distinguished Professor of Chemistry, Gill Chair in Biomolecular Sciences, Department of Chemistry, Indiana University
8:15 a.m. – 8:45 a.m.	Peptides for Molecular Recognition and Brain Delivery Ernest Giralt, Ph.D. Professor, Institute for Research in Biomedicine (IRB Barcelona)
8:45 a.m. – 9:15 a.m.	Novel Pairings in the Human Peptide-Receptor Signaling System David Gloriam, Ph.D. Professor, University of Copenhagen
9:15 a.m. – 9:45 a.m.	Chimeric Macrocyclic Peptide Antibiotics Against WHO Priority 1 Gram-Negative Bacteria Targeting both Lipopolysaccharide and BamA Daniel Obrecht, Ph.D. CSO, Polyphor Ltd
9:45 a.m. – 10:30 a.m.	Break
10:30 a.m. – 12:00 p.m.	Plenary Lectures Moderator: Jordi Alsina, Ph.D. Research Fellow, Peptide Lead Optimization Biotechnology Discovery Research, Eli Lilly and Company
10:30 a.m. – 11:15 a.m.	Cyclic Cell-Penetrating Peptides: Mechanism of Action and Applications Dehua Pei, Ph.D. Kimberly Professor of Chemistry and Biochemistry, The Ohio State University
11:15 a.m. – 12:00 p.m.	GI Device Development in a Few Movements Giovanni Traverso, MB, BChir, Ph.D. Assistant Professor, Department of Mechanical Engineering, Massachusetts Institute of Technology, Assistant Professor of Medicine (part-time), Division of Gastroenterology, Brigham and Women’s Hospital, Harvard Medical School
12:00 p.m. – 1:00 p.m.	Lunch Break
1:00 p.m. – 2:30 p.m.	Session IV Moderator: Michael Dunn, Ph.D. Sr. Director Scientific Information & Intelligence Ferring Research Institute
1:00 p.m. – 1:30 p.m.	GEN-009: A Neoantigen Vaccine Based on Autologous Peptide Immune Responses GEN-011: Transforming T cell Therapy for Solid Tumors Daniel B. DeOliveira, Ph.D., PMP Senior Director; Peptide Dev., Tech. Ops. & Mfg. Genocea Biosciences Inc.
1:30 p.m. – 2:00 p.m.	Vasopressin: Old Dog. New Tricks Michael J. Brownstein M.D. Ph.D. Senior Vice President, Drug Development, Azevan Pharmaceuticals
2:00 p.m. – 2:30 p.m.	Dual Myristic Acid (Myr) and Trans Activator of Transcription (Tat) Conjugated Peptides: A Potential Platform Technology for Intracellular Cargo Delivery Lindon H. Young, Ph.D. Professor of Pharmacology, Philadelphia College of Osteopathic Medicine Founder & Chief Science Officer of Young Therapeutics Kerry-Anne A. Perkins, D.O. Obstetrician & Gynecologist, Virtua Memorial Hospital
2:30 p.m. – 2:45 p.m.	Closing Remarks Adrienne Day, Ph.D. Director and Treasurer, Peptide Therapeutics Foundation Founder and Principal, Blue Gum Advisors
2:45 p.m. – 4:45 p.m.	Poster Break Out Sessions